WHITEHAWK THERAPEUTICS, INC. Cost of Revenue
WHITEHAWK THERAPEUTICS, INC. (WHWK) reported Cost of Revenue of $0 for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Expense Statement
us-gaap:CostOfGoodsAndServicesSold · last filed 2026-08-06
- WHITEHAWK THERAPEUTICS, INC. cost of goods and services sold for the quarter ending 2026-06-30 was $0.00.
- WHITEHAWK THERAPEUTICS, INC. cost of goods and services sold for the quarter ending 2026-03-31 was $0.00, a 100.00% decline year-over-year.
- WHITEHAWK THERAPEUTICS, INC. cost of goods and services sold for the quarter ending 2025-12-31 was $0.00, a 100.00% decline year-over-year.
- WHITEHAWK THERAPEUTICS, INC. cost of goods and services sold for the quarter ending 2025-09-30 was $0.00, a 100.00% decline year-over-year.
- WHITEHAWK THERAPEUTICS, INC. cost of goods and services sold for fiscal 2025 was $760.00K, a 74.87% decline from fiscal 2024.
- WHITEHAWK THERAPEUTICS, INC. cost of goods and services sold for fiscal 2024 was $3.02M, a 7.65% increase from fiscal 2023.
- WHITEHAWK THERAPEUTICS, INC. cost of goods and services sold for fiscal 2023 was $2.81M, a 110.41% increase from fiscal 2022.
- WHITEHAWK THERAPEUTICS, INC. cost of goods and services sold for fiscal 2022 was $1.33M.
| Period end | Cost of Goods and Services Sold 3 month | Cost of Goods and Services Sold 6 month | Cost of Goods and Services Sold 9 month | Cost of Goods and Services Sold 12 month |
|---|---|---|---|---|
| 2026-06-30 | $0.00 10-Q · filed 2026-08-06 | $0.00 10-Q · filed 2026-08-06 | $0.00 derived: sum of 3 quarters · filed 2026-08-06 | $0.00 derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $0.00 10-Q · filed 2026-05-07 | $0.00 derived: sum of 2 quarters · filed 2026-05-07 | $0.00 derived: sum of 3 quarters · filed 2026-05-07 | $0.00 derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $0.00 derived: sum of 2 quarters · filed 2026-03-12 | $0.00 derived: sum of 3 quarters · filed 2026-08-06 | $760.00K 10-K · filed 2026-03-12 |
| 2025-09-30 | $0.00 10-Q · filed 2025-11-06 | $0.00 derived: sum of 2 quarters · filed 2026-08-06 | $760.00K 10-Q · filed 2025-11-06 | $1.55M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $0.00 10-Q · filed 2026-08-06 | $760.00K 10-Q · filed 2026-08-06 | $1.55M derived: sum of 3 quarters · filed 2026-08-06 | $2.35M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $760.00K 10-Q · filed 2026-05-07 | $1.55M derived: sum of 2 quarters · filed 2026-05-07 | $2.35M derived: sum of 3 quarters · filed 2026-05-07 | $3.13M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $790.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $1.59M derived: sum of 2 quarters · filed 2026-03-12 | $2.37M derived: sum of 3 quarters · filed 2026-03-12 | $3.02M 10-K · filed 2026-03-12 |
| 2024-09-30 | $804.00K 10-Q · filed 2025-11-06 | $1.58M derived: sum of 2 quarters · filed 2025-11-06 | $2.23M 10-Q · filed 2025-11-06 | $3.16M derived: sum of 4 quarters · filed 2025-11-06 |
| 2024-06-30 | $778.00K 10-Q · filed 2025-08-07 | $1.43M 10-Q · filed 2025-08-07 | $2.36M derived: sum of 3 quarters · filed 2025-08-07 | $3.05M derived: sum of 4 quarters · filed 2025-08-07 |
| 2024-03-31 | $652.00K 10-Q · filed 2025-05-08 | $1.58M derived: sum of 2 quarters · filed 2025-05-08 | $2.28M derived: sum of 3 quarters · filed 2025-05-08 | $2.93M derived: sum of 4 quarters · filed 2025-05-08 |
| 2023-12-31 | $927.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-28 | $1.62M derived: sum of 2 quarters · filed 2025-03-28 | $2.28M derived: sum of 3 quarters · filed 2025-03-28 | $2.81M 10-K · filed 2025-03-28 |
| 2023-09-30 | $697.00K 10-Q · filed 2024-11-06 | $1.35M derived: sum of 2 quarters · filed 2024-11-06 | $1.88M 10-Q · filed 2024-11-06 | $2.10M derived: sum of 4 quarters · filed 2024-11-06 |
| 2023-06-30 | $656.00K 10-Q · filed 2024-08-07 | $1.19M 10-Q · filed 2024-08-07 | $1.41M derived: sum of 3 quarters · filed 2024-08-07 | $2.00M derived: sum of 4 quarters · filed 2024-08-07 |
| 2023-03-31 | $529.00K 10-Q · filed 2024-05-08 | $751.00K derived: sum of 2 quarters · filed 2024-05-08 | $1.34M derived: sum of 3 quarters · filed 2024-05-08 | $1.69M derived: sum of 4 quarters · filed 2024-05-08 |
| 2022-12-31 | $222.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-13 | $815.00K derived: sum of 2 quarters · filed 2024-03-13 | $1.16M derived: sum of 3 quarters · filed 2024-03-13 | $1.33M 10-K · filed 2024-03-13 |
| 2022-09-30 | $593.00K 10-Q · filed 2023-11-08 | $934.00K derived: sum of 2 quarters · filed 2023-11-08 | $1.11M 10-Q · filed 2023-11-08 | $1.11M derived: sum of 4 quarters · filed 2023-11-08 |
| 2022-06-30 | $341.00K 10-Q · filed 2023-08-09 | $520.00K 10-Q · filed 2023-08-09 | $520.00K derived: sum of 3 quarters · filed 2023-08-09 | $520.00K derived: sum of 4 quarters · filed 2023-08-09 |
| 2022-03-31 | $179.00K 10-Q · filed 2023-05-10 | $179.00K derived: sum of 2 quarters · filed 2023-05-10 | $179.00K derived: sum of 3 quarters · filed 2023-05-10 | $179.00K derived: sum of 4 quarters · filed 2023-05-10 |
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-29 | $0.00 derived: sum of 2 quarters · filed 2023-03-29 | $0.00 derived: sum of 3 quarters · filed 2023-03-29 | $0.00 10-K · filed 2023-03-29 |
| 2021-09-30 | $0.00 10-Q · filed 2022-11-09 | $0.00 derived: sum of 2 quarters · filed 2022-11-09 | $0.00 10-Q · filed 2022-11-09 | |
| 2021-06-30 | $0.00 10-Q · filed 2022-08-10 | $0.00 10-Q · filed 2022-08-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| Foghorn Therapeutics Inc. (FHTX) | United States | $0.213B | -4.43 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |